Loading...
XSESBSL
Market cap1.13bUSD
Dec 20, Last price  
0.83SGD
1D
-1.20%
1Q
-8.84%
Jan 2017
-42.31%
Name

Raffles Medical Group Ltd

Chart & Performance

D1W1MN
XSES:BSL chart
P/E
17.00
P/S
2.16
EPS
0.05
Div Yield, %
4.61%
Shrs. gr., 5y
0.88%
Rev. gr., 5y
7.68%
Revenues
708m
-7.63%
101,456,000112,898,000134,248,000168,659,000200,769,000218,610,000239,123,000272,783,000311,633,000340,989,000374,641,000410,535,000473,608,000477,583,000489,135,000522,038,000568,203,000723,791,000766,537,000708,032,000
Net income
90m
-37.05%
9,481,00011,958,00015,713,00035,863,00031,547,00037,882,00045,265,00050,396,00056,849,00084,892,00067,639,00069,291,00070,210,00070,779,00071,056,00060,273,00065,891,00084,171,000143,214,00090,150,000
CFO
189m
-3.52%
15,441,00015,626,00019,663,00040,071,00040,074,00047,209,00049,210,00063,258,00069,545,00071,191,00093,496,00072,816,00078,854,00082,693,00091,528,000111,147,000133,146,000160,112,000196,225,000189,312,000
Dividend
May 13, 20240.024 SGD/sh
Earnings
Feb 24, 2025

Profile

Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan. The company operates through Healthcare Services, Hospital Services, and Investment Holdings segments. Its flagship hospital is the Raffles Hospital, a tertiary care hospital that offers cancer, children and women care, Chinese medicine, counselling, dental, dialysis, diabetes and endocrinology, ear, nose, throat, eye, fertility, heart, internal medicine, neuroscience, pain management, rehabilitation, orthopedic, skin and aesthetics, surgery, nuclear medicine, and urology services. The company also offers emergency services, family medicine services, health screening, and various multi-disciplinary specialist clinic services. In addition, it trades in pharmaceutical and nutraceutical products, and diagnostic equipment; provides advisory and consultancy services, and develops IT solutions; and engages in research and experimental development on biotechnology, and life and medical science. Raffles Medical Group Ltd was founded in 1976 and is based in Singapore.
URL
https://www.rafflesmedicalgroup.com/
IPO date
Apr 11, 1997
Employees
2,800
Domiciled in
SG
Incorporated in
SG

Valuation

Title
SGD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
708,032
-7.63%
766,537
5.91%
723,791
27.38%
Cost of revenue
392,097
126,556
143,270
Unusual Expense (Income)
NOPBT
315,935
639,981
580,521
NOPBT Margin
44.62%
83.49%
80.21%
Operating Taxes
28,349
48,002
31,868
Tax Rate
8.97%
7.50%
5.49%
NOPAT
287,586
591,979
548,653
Net income
90,150
-37.05%
143,214
70.15%
84,171
27.74%
Dividends
(70,683)
(52,015)
(37,349)
Dividend yield
3.50%
1.99%
1.45%
Proceeds from repurchase of equity
(5,698)
(18,311)
2,365
BB yield
0.28%
0.70%
-0.09%
Debt
Debt current
27,785
19,326
106,540
Long-term debt
134,673
99,917
115,513
Deferred revenue
Other long-term liabilities
8,083
56,478
50,316
Net debt
(181,140)
(409,558)
(318,792)
Cash flow
Cash from operating activities
189,312
196,225
160,112
CAPEX
(20,525)
(25,299)
(52,869)
Cash from investing activities
(21,419)
(22,832)
(52,199)
Cash from financing activities
(81,549)
(183,702)
(46,873)
FCF
258,355
650,269
491,196
Balance
Cash
343,598
253,127
264,988
Long term investments
275,674
275,857
Excess cash
308,196
490,474
504,655
Stockholders' equity
1,075,335
1,057,298
976,620
Invested Capital
868,435
642,920
691,318
ROIC
38.06%
88.74%
81.20%
ROCE
26.85%
56.06%
48.13%
EV
Common stock shares outstanding
1,868,552
1,866,347
1,876,460
Price
1.08
-22.86%
1.40
2.19%
1.37
37.00%
Market cap
2,018,036
-22.77%
2,612,886
1.64%
2,570,750
39.69%
EV
1,853,010
2,218,678
2,267,784
EBITDA
354,182
680,197
619,847
EV/EBITDA
5.23
3.26
3.66
Interest
6,078
6,882
6,356
Interest/NOPBT
1.92%
1.08%
1.09%